<?xml version='1.0' encoding='utf-8'?>
<chapter num="03" heading="Certified Medicine Aides" title_num="10" subtitle_num="39">
  <regulation prefix="Regulation" num=".01" heading="Definitions.">
    <paragraph num="A.">
      <text>In this chapter, the following terms have the meanings indicated.</text>
    </paragraph>
    <paragraph num="B.">
      <text>Terms Defined.</text>
      <paragraph num="(1)">
        <text>“Board” means the Maryland Board of Nursing.</text>
      </paragraph>
      <paragraph num="(2)">
        <text>“Certificate” means a certificate issued by the Board to practice as a nursing assistant in this State.</text>
      </paragraph>
      <paragraph num="(3)">
        <text>“Certified medicine aide (CMA)” means an individual certified in good standing as an active CNA who:</text>
        <paragraph num="(a)">
          <text>Satisfies the requirements of COMAR 10.39.03.02; and</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Is further certified by the Board to accept delegation of administration of certain medications.</text>
        </paragraph>
      </paragraph>
      <paragraph num="(4)">
        <text>Certified Nursing Assistant (CNA).</text>
        <paragraph num="(a)">
          <text>“Certified nursing assistant (CNA)” means an individual, regardless of title, who, for compensation and subject to regulations adopted by the Board, routinely performs:</text>
          <paragraph num="(i)">
            <text>Nursing tasks delegated by a registered nurse, licensed practical nurse, or advanced practice registered nurse; or</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>Technical tasks delegated by a licensed certified midwife.</text>
          </paragraph>
        </paragraph>
        <paragraph num="(b)">
          <text>“Certified nursing assistant (CNA)” does not include dialysis technician or medication technician.</text>
        </paragraph>
      </paragraph>
      <paragraph num="(5)">
        <text>Certified Nursing Assistant-I (CNA-I).</text>
        <paragraph num="(a)">
          <text>“Certified nursing assistant-I (CNA-I)” means a CNA who:</text>
          <paragraph num="(i)">
            <text>Meets the requirements set by the Board and federal law; and</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>May practice in any practice setting.</text>
          </paragraph>
        </paragraph>
        <paragraph num="(b)">
          <text>“Certified nursing assistant-I (CNA-I)” includes a:</text>
          <paragraph num="(i)">
            <text>CNA who was certified as a geriatric nursing assistant on March 31, 2026;</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>Certified medicine aide; and</text>
          </paragraph>
          <paragraph num="(iii)">
            <text>CNA who is certified pursuant to § 8-6A-05(c)(5) of the Health Occupations Article, Annotated Code of Maryland.</text>
          </paragraph>
        </paragraph>
      </paragraph>
      <paragraph num="(6)">
        <text>“Certified nursing assistant-II (CNA-II)” means a CNA who:</text>
        <paragraph num="(a)">
          <text>On March 31, 2026, was certified as a CNA but not certified as a geriatric nursing assistant; and</text>
        </paragraph>
        <paragraph num="(b)">
          <text>May not practice in a nursing facility or skilled nursing facility.</text>
        </paragraph>
      </paragraph>
      <paragraph num="(7)">
        <text>“Controlled schedule drugs” means drugs listed as Schedule I, II, III, IV, or V controlled dangerous substances under Criminal Law Article, §§5-402 — 5-406, Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(8)">
        <text>“Licensed practical nurse (LPN)” has the meaning stated in Health Occupations Article, §8-101, Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(9)">
        <text>“Registered nurse (RN)” has the meaning stated in Health Occupations Article, §8-101, Annotated Code of Maryland.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".02" heading="Certification and Qualification.">
    <paragraph num="A.">
      <text>An applicant for certification as a CMA shall provide evidence satisfactory to the Board of meeting the following requirements:</text>
      <paragraph num="(1)">
        <text>Current certification by the Board as an active CNA-1 in good standing;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Current employment and work experience as required by the Board in a setting acceptable to the Board, including:</text>
        <paragraph num="(a)">
          <text>Current employment and 2 years of full-time experience as a CNA-1 in a facility licensed under 42 CFR Part 483 et seq.; or</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Current employment and 1 year of full-time experience as a CNA-I in a facility licensed in Maryland under COMAR 10.07.02; and</text>
        </paragraph>
      </paragraph>
      <paragraph num="(3)">
        <text>Successful completion as evidenced by a certificate of completion from a Board-approved CMA training program.</text>
      </paragraph>
    </paragraph>
    <paragraph num="B.">
      <text>The community college shall submit verification of successful completion of the CMA training program to the Board within 5 business days after completion of the program in a manner prescribed by the Board.</text>
    </paragraph>
    <paragraph num="C.">
      <text>Before renewal of certification as a CMA, and subject to the requirements in Health Occupations Article, §8-6A-08, Annotated Code of Maryland, and COMAR 10.39.01.09, the applicant shall:</text>
      <paragraph num="(1)">
        <text>Successfully complete a Board-approved 8-hour medicine aide continuing education program as required by Regulation .03B of this chapter; and</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Provide satisfactory evidence of completion of 100 hours of practice as a certified medicine aide in the 2-year period preceding the date of renewal.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".03" heading="Medicine Aide Course Requirements.">
    <paragraph num="A.">
      <text>Medicine Aide Course Curriculum. The Board shall approve a CMA program that:</text>
      <paragraph num="(1)">
        <text>Requires a candidate for admission to the program have current employment and work experience as set forth in Regulation .02A(2) of this chapter;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Requires before admission that a candidate have a positive recommendation from the director of nursing in the facility where the candidate is employed;</text>
      </paragraph>
      <paragraph num="(3)">
        <text>Is at least 60 hours in length with a minimum of 30 clock hours devoted to theoretical instruction and a minimum of 30 clock hours of supervised clinical training experience in a facility licensed under COMAR 10.07.02;</text>
      </paragraph>
      <paragraph num="(4)">
        <text>Includes instruction in both theory and clinical regarding all approved routes of medication administration and the scope of responsibility of the CMA; and</text>
      </paragraph>
      <paragraph num="(5)">
        <text>Includes each of the following subjects:</text>
        <paragraph num="(a)">
          <text>Responsibilities and limitations of the CMA;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Drug standards, references, and resources;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>Legislation concerning drug utilization;</text>
        </paragraph>
        <paragraph num="(d)">
          <text>Characteristics of the elderly client or client with multiple handicaps;</text>
        </paragraph>
        <paragraph num="(e)">
          <text>Sources and purposes of drugs;</text>
        </paragraph>
        <paragraph num="(f)">
          <text>Dosage forms and methods of administration;</text>
        </paragraph>
        <paragraph num="(g)">
          <text>Drug life;</text>
        </paragraph>
        <paragraph num="(h)">
          <text>The medication order;</text>
        </paragraph>
        <paragraph num="(i)">
          <text>The pharmacy label;</text>
        </paragraph>
        <paragraph num="(j)">
          <text>The administration of nonparenteral medications;</text>
        </paragraph>
        <paragraph num="(k)">
          <text>Procedures and techniques for administering drugs;</text>
        </paragraph>
        <paragraph num="(l)">
          <text>Drug classification, related health problems, and patient care responsibilities;</text>
        </paragraph>
        <paragraph num="(m)">
          <text>Drug solutions and measurements; and</text>
        </paragraph>
        <paragraph num="(n)">
          <text>Monitoring side effects of drugs and drug interactions.</text>
        </paragraph>
      </paragraph>
    </paragraph>
    <paragraph num="B.">
      <text>Medicine Aide Continuing Education Curriculum. Continuing education courses required for continued listing as a CMA as required in Regulation .02C of this chapter shall contain:</text>
      <paragraph num="(1)">
        <text>A 3-hour core content that includes:</text>
        <paragraph num="(a)">
          <text>Current State regulations related to the role of the medicine aide;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Uses, actions, and possible interactions of and related precautions for current medications used in the care of the geriatric patient;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>New care procedures; and</text>
        </paragraph>
        <paragraph num="(d)">
          <text>Resources available to the medicine aide which clarify and expand the knowledge of the medicine aide; and</text>
        </paragraph>
      </paragraph>
      <paragraph num="(2)">
        <text>3 hours on at least three of the following topics:</text>
        <paragraph num="(a)">
          <text>Documentation;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Nutrition;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>The physiological system of the geriatric patient;</text>
        </paragraph>
        <paragraph num="(d)">
          <text>De-institutionalization of the intellectually disabled or psychiatric patient; or</text>
        </paragraph>
        <paragraph num="(e)">
          <text>Other aspects of pharmacology; and</text>
        </paragraph>
      </paragraph>
      <paragraph num="(3)">
        <text>2 hours of assessment testing administered at the completion of the continuing education course.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".04" heading="Scope of Responsibility.">
    <paragraph num="A.">
      <text>The CMA may be delegated medication administration by the RN or LPN under the following conditions:</text>
      <paragraph num="(1)">
        <text>The licensed nursing supervision requirements in Regulation .05 of this chapter have been met;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>The CMA is assigned to administer medication;</text>
      </paragraph>
      <paragraph num="(3)">
        <text>There is a written medication order;</text>
      </paragraph>
      <paragraph num="(4)">
        <text>The CMA is physically present on a continuing basis in the unit of care to accomplish the following as instructed and directed by the RN or LPN:</text>
        <paragraph num="(a)">
          <text>Monitor the therapeutic effects of the medication;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Observe and report untoward effects of the medication;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>Report observed changes in client behavior and clinical status; and</text>
        </paragraph>
        <paragraph num="(d)">
          <text>Withhold administration of the medication if necessary.</text>
        </paragraph>
      </paragraph>
    </paragraph>
    <paragraph num="B.">
      <text>The CMA may perform the following RN or LPN delegated nursing functions:</text>
      <paragraph num="(1)">
        <text>Prepare, administer, and chart medications administered:</text>
        <paragraph num="(a)">
          <text>Orally;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>By nebulizer, metered dose inhalant, and, in the case of oxygen, by nasal cannula or mask;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>Topically, excluding wound or decubitus site care;</text>
        </paragraph>
        <paragraph num="(d)">
          <text>By suppository; and</text>
        </paragraph>
        <paragraph num="(e)">
          <text>By eye, ear, and nose drops;</text>
        </paragraph>
      </paragraph>
      <paragraph num="(2)">
        <text>Prepare, administer, and chart:</text>
        <paragraph num="(a)">
          <text>Nonlegend PRN medications; and</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Controlled schedule drugs after the RN or LPN:</text>
          <paragraph num="(i)">
            <text>Makes a bedside assessment of the patient;</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>Documents the assessment; and</text>
          </paragraph>
          <paragraph num="(iii)">
            <text>Gives permission to the CMA to administer that medication; and</text>
          </paragraph>
        </paragraph>
      </paragraph>
      <paragraph num="(3)">
        <text>When the licensed nurse delegating medication administration provides access to the controlled schedule drug cabinet, sign for and administer controlled schedule drugs.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".05" heading="Supervision.">
    <text>The CMA may administer medications when:</text>
    <paragraph num="A.">
      <text>In a setting licensed under COMAR 10.07.02, the licensed nurse is physically present and immediately available on the unit of care in which the client resides to provide direct supervision of any client who receives medication administered by the CMA; and</text>
    </paragraph>
    <paragraph num="B.">
      <text>In a setting licensed under 42 CFR Part 483 et seq., the licensed nurse is on-site and physically available to the CMA and the CMA administers medications only to clients whose clinical status is:</text>
      <paragraph num="(1)">
        <text>Chronic;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Stable;</text>
      </paragraph>
      <paragraph num="(3)">
        <text>Uncomplicated; and</text>
      </paragraph>
      <paragraph num="(4)">
        <text>Permitting placement in the community.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".06" heading="Unlawful Delegation.">
    <text>The RN or LPN may not delegate the following duties to the CMA:</text>
    <paragraph num="A.">
      <text>Transcription of original physician orders to medication and treatment administration records, charts, or Kardexes;</text>
    </paragraph>
    <paragraph num="B.">
      <text>Charge level responsibilities, including receiving instructions for or being assigned to such responsibilities;</text>
    </paragraph>
    <paragraph num="C.">
      <text>Administration of medication to clients whose clinical status is acutely unstable, complex, or medically fragile in a setting licensed under 42 CFR Part 483 et seq.;</text>
    </paragraph>
    <paragraph num="D.">
      <text>Administration of medication by way of the following routes:</text>
      <paragraph num="(1)">
        <text>Injection;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Intravenous route; and</text>
      </paragraph>
      <paragraph num="(3)">
        <text>By way of a tube inserted in a cavity of the body, including nasogastric or gastrostomy tube feeding;</text>
      </paragraph>
    </paragraph>
    <paragraph num="E.">
      <text>Client teaching;</text>
    </paragraph>
    <paragraph num="F.">
      <text>Acceptance of verbal or telephone orders; and</text>
    </paragraph>
    <paragraph num="G.">
      <text>Responsibility for maintaining possession of the keys or access code to the locked container for controlled schedule drugs.</text>
    </paragraph>
  </regulation>
  <annotations>
    <annotation type="Authority">Health Occupations Article, §§8-205(a) and (c) and 8-6A-01 — 8-6A-16, Annotated Code of MarylandChs. 818 and 819, Acts of 2024; Ch. 416, Acts of 2025</annotation>
    <annotation type="History" subtype="Administrative History">Effective date: February 5, 2001 (28:2 Md. R. 100)</annotation>
    <annotation type="History" subtype="Administrative History">Regulation .02 amended as an emergency provision effective October 30, 2001 (28:23 Md. R. 2052); amended permanently effective February 18, 2002 (29:3 Md. R. 221)</annotation>
    <annotation type="History" subtype="Administrative History">Regulations .01 — .04 repealed and new Regulations .01 — .06 adopted as an emergency provision effective January 19, 2005 (32:3 Md. R. 287); adopted permanently effective March 14, 2005 (32:5 Md. R. 580)</annotation>
    <annotation type="History" subtype="Administrative History">Regulation .01B amended as an emergency provision effective April 3, 2026 (53:9 Md. R. 411); amended permanently effective June 8, 2026 (53:11 Md. R. 484)</annotation>
    <annotation type="History" subtype="Administrative History">Regulation .02A, C amended as an emergency provision effective April 3, 2026 (53:9 Md. R. 411); amended permanently effective June 8, 2026 (53:11 Md. R. 484)</annotation>
    <annotation type="History" subtype="Administrative History">Regulation .02C amended effective August 25, 2008 (35:17 Md. R. 1489)</annotation>
    <annotation type="History" subtype="Administrative History">Regulation .03B amended effective April 15, 2013 (40:7 Md. R. 612)</annotation>
  </annotations>
</chapter>